• Vireo Growth agreed to acquire C21 Investments in an all-share deal under which C21 holders get 0.02 Vireo subordinate voting shares per C21 share.
• The combination is expected to expand Vireo’s Nevada footprint to about 15 dispensaries and 158,000 square feet of cultivation and manufacturing capacity.
• C21’s board-backed process included a special committee review and a fairness opinion from Needham on the consideration to C21 shareholders.
• C21 shareholders are expected to vote on the deal at a meeting planned for the third quarter of 2026.
• The agreement includes a termination fee of US$ 3 million in certain scenarios, including if C21 accepts a superior proposal.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vireo Growth Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606150700PRIMZONEFULLFEED9746840) on June 15, 2026, and is solely responsible for the information contained therein.